Key result
A review of clinical trials and guidelines discusses the indications and treatment schemes for metoprolol and carvedilol in patients with acute myocardial infarction.
Why the study?
When and which beta-blocker (metoprolol or carvedilol) should be preferred in the therapy of acute myocardial infarction?
When and which beta-blocker (metoprolol or carvedilol) should be preferred in the therapy of acute myocardial infarction?
Answers are grounded in this paper and cite their sources.
This review summarizes the evidence and guideline recommendations for choosing between metoprolol and carvedilol in the medical management of acute myocardial infarction.
Results of large randomized clinical trails on beta-blockers therapy of myocardial infarction (MI) with ST segment elevation (COMMIT/CCS-2, CAPRICORN) are analyzed. Last changes in guidelines regarding beta-blockers prescription to patients with MI are presented. Data of the studies comparing influence of metoprolol tartrate and carvedilol on MI pathogenesis are presented. Possible indications and treatment schemes for carvedilol in patients with acute MI are discussed.
No takes yet. Share an insight, caveat, or question.
Гарифуллин et al. (2009) conducted a review in acute myocardial infarction. metoprolol and carvedilol was evaluated. A review of clinical trials and guidelines discusses the indications and treatment schemes for metoprolol and carvedilol in patients with acute myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: